Search clinical trials for: MDX2001
Total 27 results
-
ModeX Therapeutics, An OPKO Health CompanyNot yet recruitingCervical Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Prostate Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Colon Cancer | Thyroid Cancer | Renal Cancer | Biliary Tract Cancer | Hepatocellular Cancer | GastroEsophageal Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
M.D. Anderson Cancer CenterMologen AGActive, not recruitingMelanoma | Advanced CancersUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...Completed
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompleted
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
M.D. Anderson Cancer CenterRecruitingRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLung Cancer | Liver CancerUnited States
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Andrew J. Armstrong, MDBristol-Myers SquibbRecruitingMetastatic Prostate Cancer | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
NYU Langone HealthRecruitingMelanoma | Unresectable MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterCelgeneCompletedMelanomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)WithdrawnMelanoma | Sarcoma
-
Dana-Farber Cancer InstituteBristol-Myers SquibbRecruitingMeningiomasUnited States
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbTerminatedMelanomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
M.D. Anderson Cancer CenterWithdrawn
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated